Auro Impex & Chemicals H1 FY27 Sales Fall 13.3%, PAT Rises

For the half-year ended September 30, 2026, Auro Impex & Chemicals Limited reported consolidated sales of ₹117 crore, down 13.3% year-on-year, while net profit rose 6.2% to ₹2.1 crore. The results were approved by the board on November 12, 2026, alongside an amendment to its insider-trading code.

What did Auro Impex & Chemicals report for H1 FY27?

Auro Impex & Chemicals reported sales of ₹117 crore for H1 FY27, compared with ₹135 crore in the half-year ended September 2025. Sales were, however, 1.8% higher than ₹115 crore reported in the immediately preceding half-year ended March 2026.

Operating profit increased 14.3% year-on-year to ₹4.6 crore from ₹4 crore. The operating profit margin improved by 94 basis points to 3.9% from 3% a year earlier, although it was lower than the 4.3% margin in the March 2026 half-year. Net profit stood at ₹2.1 crore, compared with ₹2 crore in September 2025 and ₹3 crore in March 2026.

When were the H1 FY27 results approved and filed?

The board of Auro Impex & Chemicals approved the unaudited standalone and consolidated financial results for the half-year ended September 30, 2026, at its meeting on November 12, 2026. According to the filing, the meeting began at 3:00 PM and concluded at 4:00 PM.

The company had informed the NSE on November 7 that its board would meet to consider the half-yearly results. The results were filed on November 12 at 17:58, 43 days after the close of the April-September reporting period. The filing also included the limited review report from statutory auditor Jain Sonu & Associates, Chartered Accountants.

Why did profit growth differ from the sales trend?

Profit grew despite lower sales because operating profit improved from the corresponding prior-year half-year. Auro Impex & Chemicals generated an operating profit of ₹4.6 crore on sales of ₹117 crore, lifting its operating margin to 3.9% from 3% in H1 FY26.

But the profit performance was weaker against the March 2026 half-year. Net profit fell 29.2% from ₹3 crore, while operating profit declined 8.5% from ₹5 crore. The reported assessment also noted that 26% of pre-tax profit came from other income and one-off items, while other income declined to ₹0.6 crore from ₹1 crore in both comparison periods.

How do the H1 FY27 numbers compare with Auro Impex's trend?

Auro Impex & Chemicals' H1 FY27 sales and profit were below the company's stated trend measures. Sales of ₹117 crore were 9.5% below the ₹129 crore trend figure, and net profit of ₹2.1 crore was 15% below the ₹2.5 crore trend figure.

The comparison indicates that the improvement in year-on-year operating margin did not fully offset the lower level of sales. PAT margin increased to 1.8% from 1.5% in H1 FY26, but remained below the 2.6% recorded in the preceding half-year. EPS increased year-on-year to ₹1.74, though it was lower than ₹2.08 in March 2026.

What is the financial background before the latest results?

For the full year ended March 31, 2026, Auro Impex & Chemicals reported sales of ₹250.20 crore, compared with ₹262.95 crore in the prior year. Total revenue, including other income, was ₹251.82 crore, against ₹264.71 crore a year earlier.

Full-year net income for FY26 was ₹4.16 crore, down from ₹4.63 crore in FY25. Basic and diluted earnings per share from continuing operations were ₹3.41, compared with ₹3.79 in the previous year. The company's annual results were approved by the board on May 23, 2026.

What does the filing mean for investors and operations?

The H1 FY27 filing shows that Auro Impex & Chemicals improved operating profitability on a year-on-year basis despite a 13.3% sales decline. Investors tracking the company will also note that the sequential figures were softer, with both operating profit and net profit below the March 2026 half-year.

The board also amended the Code of Conduct for Prevention of Insider Trading under Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015. This was a governance-related board action disclosed alongside the financial results and does not change the reported H1 operating figures.

Conclusion

Auro Impex & Chemicals closed H1 FY27 with lower sales but higher year-on-year operating profit, margin and net profit. Sales of ₹117 crore remained below both the prior-year figure and the company's stated trend, while the profit comparison with the preceding half-year showed a decline.

The next item to watch is the company's subsequent financial disclosure and whether sales, operating margin and other income change from the H1 FY27 levels. The company has filed both standalone and consolidated half-yearly results, with the latest results subject to a limited review by its statutory auditor.